Suchergebnis | Hamburg Open Science

Facetten

203 Einträge gefunden

Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.
2006 - Forschungsinformationssystem des UKE
Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes.
2006 - Forschungsinformationssystem des UKE
Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits.
2006 - Forschungsinformationssystem des UKE
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
2006 - Forschungsinformationssystem des UKE
The 2988G>A polymorphism affects splicing of a CYP2D6 minigene.
2006 - Forschungsinformationssystem des UKE
The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling.
2006 - Forschungsinformationssystem des UKE
High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations.
2006 - Forschungsinformationssystem des UKE
Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium.
2005 - Forschungsinformationssystem des UKE
Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.
2004 - Forschungsinformationssystem des UKE
Formation of molecular complexes by N-methyl-D-aspartate receptor subunit NR2B and ryanodine receptor 2 in neonatal rat myocard.
2004 - Forschungsinformationssystem des UKE
CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.
2004 - Forschungsinformationssystem des UKE
[Beta blockers in cardiac insufficiency. When, how much and which substance]
2004 - Forschungsinformationssystem des UKE
Ouabain treatment is associated with upregulation of phosphatase inhibitor-1 and Na+/Ca(2+)-exchanger and beta-adrenergic sensitization in rat hearts.
2004 - Forschungsinformationssystem des UKE
Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.
2004 - Forschungsinformationssystem des UKE
Beta-adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase.
2003 - Forschungsinformationssystem des UKE
Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes.
2003 - Forschungsinformationssystem des UKE
Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure.
2003 - Forschungsinformationssystem des UKE
Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes.
2003 - Forschungsinformationssystem des UKE
Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment.
2002 - Forschungsinformationssystem des UKE
Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.
2002 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.

Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes.

Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits.

Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.

The 2988G>A polymorphism affects splicing of a CYP2D6 minigene.

The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling.

High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations.

Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium.

Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.

Formation of molecular complexes by N-methyl-D-aspartate receptor subunit NR2B and ryanodine receptor 2 in neonatal rat myocard.

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.

[Beta blockers in cardiac insufficiency. When, how much and which substance]

Ouabain treatment is associated with upregulation of phosphatase inhibitor-1 and Na+/Ca(2+)-exchanger and beta-adrenergic sensitization in rat hearts.

Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.

Beta-adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase.

Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes.

Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure.

Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes.

Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment.

Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.